PRMT5 inhibitors

Epizyme Earns $6 Million Milestone Payment from GlaxoSmithKline for Initiation of Clinical Development with First-in-Class PRMT5 Inhibitor
Yahoo
Thu, 09/15/16 - 09:26 am
Epizyme
GSK
GSK3326595
cancer
PRMT5 inhibitors